Cybex Ventures can provide an independent due diligence of proposed Series A, B and C investments in healthcare and life science companies.
The aim would be to guide investors on the risks and potential rewards of investment decisions.
This could include, but not be limited to, the following:
Independent advice to venture capital and investment companies.
Validation of assumptions in
the Information Memorandum (IM)
Exit strategies
M&A company analysis: independent and confidential review of current plans
